News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
499,389 Results
Type
Article (22674)
Company Profile (180)
Press Release (476535)
Section
Business (147537)
Career Advice (768)
Deals (26259)
Drug Delivery (52)
Drug Development (56739)
Employer Resources (71)
FDA (12116)
Job Trends (10512)
News (245048)
Policy (19789)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (8)
2024 BioMidwest Digital (3)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (2)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (1875)
Academic (1)
Adcomms (8)
Allergies (60)
Alliances (42270)
ALS (46)
Alzheimer's disease (1018)
Antibody-drug conjugate (ADC) (73)
Approvals (12132)
Artificial intelligence (247)
Autoimmune disease (8)
Automation (12)
Bankruptcy (216)
Best Places to Work (9029)
BIOSECURE Act (9)
Biosimilars (25)
Biotechnology (140)
Bladder cancer (41)
Brain cancer (20)
Breast cancer (174)
Cancer (1462)
Cardiovascular disease (103)
Career advice (678)
Career pathing (13)
CAR-T (113)
Cell therapy (326)
Cervical cancer (11)
Clinical research (45840)
Collaboration (679)
Compensation (216)
Complete response letters (8)
COVID-19 (1594)
CRISPR (35)
C-suite (164)
Cystic fibrosis (77)
Data (1508)
Decentralized trials (1)
Denatured (18)
Depression (25)
Diabetes (156)
Diagnostics (5459)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (15)
Drug discovery (93)
Drug pricing (47)
Drug shortages (19)
Duchenne muscular dystrophy (39)
Earnings (55368)
Editorial (19)
Employer branding (9)
Employer resources (62)
Events (74152)
Executive appointments (509)
FDA (12957)
Featured Employer (36)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (567)
Gene editing (89)
Generative AI (25)
Gene therapy (211)
GLP-1 (365)
Government (2220)
Grass and pollen (2)
Guidances (40)
Healthcare (13558)
Huntington's disease (13)
IgA nephropathy (14)
Immunology and inflammation (52)
Indications (18)
Infectious disease (1687)
Inflammatory bowel disease (97)
Inflation Reduction Act (5)
Influenza (33)
Intellectual property (64)
Interviews (99)
IPO (12571)
IRA (22)
Job creations (1913)
Job search strategy (599)
Kidney cancer (7)
Labor market (13)
Layoffs (170)
Leadership (6)
Legal (3965)
Liver cancer (56)
Lung cancer (201)
Lymphoma (92)
Machine learning (2)
Management (26)
Manufacturing (203)
MASH (38)
Medical device (12181)
Medtech (12186)
Mergers & acquisitions (14128)
Metabolic disorders (383)
Multiple sclerosis (44)
NASH (9)
Neurodegenerative disease (43)
Neuropsychiatric disorders (4)
Neuroscience (1320)
NextGen: Class of 2025 (4584)
Non-profit (2437)
Northern California (1812)
Now hiring (11)
Obesity (193)
Opinion (142)
Ovarian cancer (60)
Pain (56)
Pancreatic cancer (63)
Parkinson's disease (93)
Partnered (12)
Patents (164)
Patient recruitment (74)
Peanut (37)
People (42029)
Pharmaceutical (31)
Pharmacy benefit managers (6)
Phase I (15498)
Phase II (20337)
Phase III (14349)
Pipeline (698)
Podcasts (38)
Policy (52)
Postmarket research (1178)
Preclinical (6542)
Press Release (69)
Prostate cancer (61)
Psychedelics (15)
Radiopharmaceuticals (229)
Rare diseases (230)
Real estate (4068)
Recruiting (28)
Regulatory (14793)
Reports (22)
Research institute (1840)
Resumes & cover letters (103)
Rett syndrome (2)
RNA editing (2)
RSV (28)
Schizophrenia (33)
Series A (97)
Series B (63)
Service/supplier (10)
Sickle cell disease (29)
Southern California (1574)
Special edition (2)
Sponsored (25)
Startups (2929)
State (2)
Stomach cancer (5)
Supply chain (41)
The Weekly (18)
United States (16022)
Vaccines (381)
Venture capitalists (26)
Webinars (8)
Weight loss (102)
Women's health (19)
Worklife (6)
Date
Today (114)
Last 7 days (474)
Last 30 days (2235)
Last 365 days (27335)
2025 (5297)
2024 (28527)
2023 (32845)
2022 (42557)
2021 (45454)
2020 (42627)
2019 (34782)
2018 (25939)
2017 (25477)
2016 (23671)
2015 (27621)
2014 (20258)
2013 (16445)
2012 (17784)
2011 (18477)
2010 (17081)
Location
Africa (464)
Alabama (39)
Alaska (6)
Arizona (126)
Arkansas (12)
Asia (33165)
Australia (6478)
California (4161)
Canada (1458)
China (347)
Colorado (208)
Connecticut (225)
Delaware (104)
Europe (66798)
Florida (612)
Georgia (139)
Idaho (36)
Illinois (333)
India (21)
Indiana (262)
Iowa (4)
Japan (119)
Kansas (84)
Kentucky (12)
Louisiana (7)
Maine (49)
Maryland (611)
Massachusetts (3117)
Michigan (187)
Minnesota (285)
Mississippi (2)
Missouri (63)
Montana (29)
Nebraska (17)
Nevada (44)
New Hampshire (67)
New Jersey (1211)
New Mexico (25)
New York (1211)
North Carolina (683)
North Dakota (7)
Northern California (1812)
Ohio (137)
Oklahoma (10)
Oregon (23)
Pennsylvania (915)
Puerto Rico (8)
Rhode Island (19)
South America (725)
South Carolina (16)
South Dakota (1)
Southern California (1574)
Tennessee (75)
Texas (622)
Utah (123)
Virginia (109)
Washington D.C. (26)
Washington State (437)
West Virginia (3)
Wisconsin (36)
499,389 Results for "aurigene discovery technologies limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Aurigene Pharmaceutical Services Limited, a global CRDMO, and Edity announce a strategic collaboration in cell therapy
Aurigene will provide cell therapy discovery services to Edity to support the latter’s clinical development
July 2, 2024
·
3 min read
Aurigene Pharmaceutical Services Limited, a global CRDMO, announces the opening of its biologics facility offering process development and clinical scale manufacturing capabilities
Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley
June 3, 2024
·
4 min read
Aurigene Pharmaceutical Services Ltd. introduces Aurigene.AI™, an artificial intelligence (AI) and machine learning (ML) assisted drug discovery platform
Aurigene.AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene’s core expertise in synthesizing and testing the molecules in vitro and in vivo. The platform consists of a meticulously curated database that serves as training data. The modular platform allows users flexibility in selecting suitable AI models from a set of generative, predictive, and computational algorithms. It utilizes an iterative ML process for ratio
April 3, 2024
·
3 min read
Aurigene Pharmaceutical Services Ltd., and Vipergen announce a strategic partnership for offering DNA encoded library (DEL) screening and integrated drug discovery services.
Aurigene Pharmaceutical Services Ltd. (Aurigene), a global contract research, development, and manufacturing services organization (CRDMO), and Vipergen ApS, a niche small-molecule drug discovery service provider specialized in DEL technologies, entered into a strategic partnership.
April 19, 2024
·
3 min read
Press Releases
AuriGen Medical Pioneers Next-Generation Atrial Fibrillation Technology with First-in-Human Success
October 15, 2024
·
2 min read
Drug Development
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
October 8, 2024
·
2 min read
Business
Aurigene Discovery Technologies Limited Announces Drug Discovery, Development and Commercialization Partnership with EQRx
The collaboration combines Aurigene’s small molecule drug discovery platform and EQRx’s pioneering business model to accelerate the development of drug candidates in the areas of oncology and immune-inflammatory diseases and improve global access to innovative medicines.
July 5, 2022
·
2 min read
Aurigene Pharmaceutical Services to expand biologics CDMO capacity with a new biomanufacturing facility
Aurigene Pharmaceutical Services Limited (Aurigene), a contract research, development, and manufacturing services organization and a step-down subsidiary of Dr. Reddy’s Laboratories
May 23, 2023
·
4 min read
Biotech Bay
AbTherx Opens Antibody Discovery Technologies Research Center
AbTherx, Inc., a biotechnology company with innovative technologies that enable and accelerate antibody discovery, announced the opening of its new antibody discovery technologies research center.
June 18, 2024
·
3 min read
Press Releases
Nona Biosciences Integrates Cutting-Edge AI Technology to Enhance Its Fully Human Antibody Platform, Accelerating Antibody Discovery Across Key Therapeutic Areas
March 7, 2025
·
3 min read
1 of 49,939
Next